| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/30/2003 | CN1107115C System for expression of heterologous antigens as fusion proteins |
| 04/30/2003 | CN1107072C Programing cell death induced molecule II |
| 04/30/2003 | CN1106858C Vaccine composition having antitumour activity and use there of in therapy of malignant diseases |
| 04/30/2003 | CN1106846C Antitumor agent |
| 04/29/2003 | US6555734 Modified dihydroflavonol 4-reductase (DFR) nucleic acids;encoding the modified DFR characterized by its ability to reduce dihydrokaempferol preferentially and increase the content of pelargonidin-based pigments |
| 04/29/2003 | US6555733 Genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use |
| 04/29/2003 | US6555732 Rac-like genes and methods of use |
| 04/29/2003 | US6555674 Nucleotide sequences for use in controlling preferential gene expression and heterologous gene expression |
| 04/29/2003 | US6555673 Synthetic promoters |
| 04/29/2003 | US6555672 Growth differentiation factor promoter and uses therefor |
| 04/29/2003 | US6555670 Specifically expressed in haploid cells of the testis, located on the X-chromosome of a mammal; given nucleotide sequence; homologous to the drosophila gcl gene |
| 04/29/2003 | US6555669 Nucleotide sequences coding preferential oligopeptide for use in human therapeutics and diagnostics; for use in the treatment of cancer and Parkinson's Disease |
| 04/29/2003 | US6555668 Comprising a non-nucleotide in a single-stranded region; hammerhead ribozyme having a non-nucleotide in the catalytic core; synthesis of abasic ribonucleoside mimetics |
| 04/29/2003 | US6555667 Hypoxia-regulated genes |
| 04/29/2003 | US6555666 Transcripts encoding immunomodulatory polypeptides |
| 04/29/2003 | US6555657 Isolated transcription factor for an alpha-amylase promoter in filamentous fungi |
| 04/29/2003 | US6555655 Novel insecticidal polypeptides of given amino acid sequence obtained by culturing Bacillus thuringiensis NRRL B-21915 or NRRL B-21916 cells |
| 04/29/2003 | US6555653 Compounds for diagnosis of tuberculosis and methods for their use |
| 04/29/2003 | US6555652 Tumor antigen peptide derivatives |
| 04/29/2003 | US6555520 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and immunologicval disorders |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555376 Comprises dissolving surfactants in oil to obtain reverse calcium phosphate micelles of DNA and/or RNA |
| 04/29/2003 | US6555375 Methods for somatic embryo formation and plant regeneration of Beta vulgaris |
| 04/29/2003 | US6555373 Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof |
| 04/29/2003 | US6555371 Enzyme which synthesizes ganglioside by transferring sialic acid to a galactose residue of lactosylceramide |
| 04/29/2003 | US6555370 Bifunctional selectable fusion genes |
| 04/29/2003 | US6555368 Single-chain antibody introduced into the minor capsid proteins so that the adenoviral vector can be targeted to a particular cell type |
| 04/29/2003 | US6555367 Complex of biotinylated viral vector and ligand for targeted gene delivery |
| 04/29/2003 | US6555366 Coding for a specific protein of interest in bacillus strains |
| 04/29/2003 | US6555358 Chemotherapeutic target for antiprotozoal agents |
| 04/29/2003 | US6555357 Structure-specific nucleases derived from thermostable organisms, used to cleave target-dependent cleavage structures |
| 04/29/2003 | US6555355 Mutating the genes for a number of subtilases and expressing the in suitable hosts |
| 04/29/2003 | US6555353 Methanotrophic carbon metabolism pathway genes and enzymes |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/29/2003 | US6555348 Enzyme isolated from a Bifidobacterium |
| 04/29/2003 | US6555346 Selecting a recombinant baculovirus expressing the protein, growing insect cells in a culture vessel and infecting the cells with an inoculum of baculovirus at a cell density of 1 x 105-5 x 106 cells/ml |
| 04/29/2003 | US6555345 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/29/2003 | US6555344 Polynucleotides encoding SRE B2 receptor |
| 04/29/2003 | US6555342 Fusion protein delivery system and uses thereof |
| 04/29/2003 | US6555341 Gamma-aminobutyric acid (GABA); stably co-transfected eukaryotic cell line capable of expressing a human GABAa receptor which comprises a theta receptor subunit and at least one receptor subunit; drug screening |
| 04/29/2003 | US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening |
| 04/29/2003 | US6555338 Given nucleotide sequence; use of polynucleotides and polypeptides in diagnostic assays, and possibly functional genomics |
| 04/29/2003 | US6555337 Protein/transcription factor in basic-helix-loop-helix (bHLH) gene family which plays role in cell determination; genetic engineering |
| 04/29/2003 | US6555335 Xylanase from Trichoderma reesei , method for production thereof, and methods employing this enzyme |
| 04/29/2003 | US6555328 Drug screening for compounds that alter phosphorylation of one or more human Period proteins |
| 04/29/2003 | US6555327 Monoclonal antibodies against S100 |
| 04/29/2003 | US6555325 Kit for screening of test compounds that modulate a heterologous G protein-coupled receptor in a yeast cell uses a mixture of yeast cells; modulators of heterologous receptors coupled to the pheromone response pathway in yeast |
| 04/29/2003 | US6555323 Assay for ABCA1 |
| 04/29/2003 | US6555319 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 04/29/2003 | US6555315 Capturing genes potentially encoding novel biochemical pathways of interest in prokaryotic systems, and screening for these pathways using high throughput screening assays |
| 04/29/2003 | US6555313 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 04/29/2003 | US6555311 Hepatitis B variants exhibiting complete or partial resistance to nucleoside analogues and/or reduced interactivity with antibodies to viral surface components; use determining if a strain will be antiviral drug resistant |
| 04/29/2003 | US6555310 Producing a multivalent polypeptide display library, starting from a library of phage including a phage capable of displaying from its outersurface a fusion protein of a coatin protein, an antibody variable domain and a tag |
| 04/29/2003 | US6555114 Immunodominant human T-cell epitopes of hepatitis C virus |
| 04/29/2003 | US6555113 Elevating the ratio of circulating HDL to circulating LDL by administering a peptide conjugate of a helper T cell epitope portion linked to a B cell epitope portion; decrease in development of atherosclerotic lesions |
| 04/29/2003 | US6555108 Implanting HSV-TK retrovirus producing cells to treat tumors |
| 04/29/2003 | US6555107 Packaging cell |
| 04/29/2003 | US6555105 Method of treatment with a RANTES antagonist polypeptide |
| 04/29/2003 | US6555091 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
| 04/29/2003 | US6554985 Methods and formulations for the separation of biological macromolecules |
| 04/29/2003 | CA2281206C Geranyl diphosphate synthase genes |
| 04/29/2003 | CA2258502C Modified factor viii |
| 04/29/2003 | CA2234690C Detection of nucleic acids by fluorescence quenching |
| 04/29/2003 | CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 04/29/2003 | CA2152898C Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same |
| 04/29/2003 | CA2105804C Kainate-binding, human cns receptors of the eaa5 family |
| 04/29/2003 | CA2102208C Binding domains in notch and delta proteins |
| 04/29/2003 | CA1341428C Synthetic insecticidal crystal protein gene |
| 04/24/2003 | WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | WO2003034149A1 Process and materials for formation of patterned films of functional materials |
| 04/24/2003 | WO2003034073A2 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 04/24/2003 | WO2003034029A2 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
| 04/24/2003 | WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 04/24/2003 | WO2003033740A2 Apparatus and method for isolating a nucleic acid |
| 04/24/2003 | WO2003033739A1 Compositions and methods for using a solid support to purify rna |
| 04/24/2003 | WO2003033738A2 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 04/24/2003 | WO2003033737A1 Gene detection method using human mitochondrial dna |
| 04/24/2003 | WO2003033734A2 Diagnostic tests for the diagnosis of copper storage disease |
| 04/24/2003 | WO2003033731A2 Methods for detecting ovarian cancer |
| 04/24/2003 | WO2003033727A1 Method of screening cell death inhibitor |
| 04/24/2003 | WO2003033722A2 Nucleic acid amplification methods |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033719A1 Cell-free protein synthesis means |
| 04/24/2003 | WO2003033718A1 Synthesis of oligonucleotides on solid support and assembly into doublestranded polynucleotides |
| 04/24/2003 | WO2003033717A1 Processes for producing isomaltose and isomaltitol and use thereof |
| 04/24/2003 | WO2003033714A1 Nucleic acid sequences that induce early flowering |
| 04/24/2003 | WO2003033713A2 Production of oil with higher erucic acid content |
| 04/24/2003 | WO2003033712A1 Chemically inducible promoters from barley and use thereof |
| 04/24/2003 | WO2003033711A1 Splicing as target for identification of novel active principles |
| 04/24/2003 | WO2003033710A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 04/24/2003 | WO2003033709A2 Regulation of human serine/threonine protein kinase |
| 04/24/2003 | WO2003033708A2 Regulation of human serine/threonine protein kinase |
| 04/24/2003 | WO2003033707A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same |
| 04/24/2003 | WO2003033706A1 Method of obtaining indolocarbazoles using biosynthetic rebeccamycin genes |
| 04/24/2003 | WO2003033705A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 04/24/2003 | WO2003033704A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/24/2003 | WO2003033703A2 Human gtp-activator protein for rab-like gtpase |
| 04/24/2003 | WO2003033702A1 METHOD OF DETECTING AND QUANTIFYING HEMOLYSIN-PRODUCING BACTERIA BY OVERWHELMINGLY DETECTING AND QUANTIFYING THERMOSTABLE HEMOLYSIN-RELATED GENES (tdh-RELATED HEMOLYSIN GENES) OF FOOD POISONING BACTERIA |
| 04/24/2003 | WO2003033701A1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 04/24/2003 | WO2003033700A1 Method for inhibiting the replication of viruses |